PROSPECTUS SUPPLEMENT NO. 10
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
INSPIRATO INCORPORATED |
|
Dated: March 15, 2023 |
|
|
By: |
/s/ Brent Handler |
|
|
Name: Brent Handler |
|
|
Title: Chief Executive Officer |
Exhibit 10.1
EMPLOYMENT AGREEMENT
This Amended and Restated Employment Agreement
(“Agreement”) is made between Inspirato LLC (the “Company”), and Web Neighbor (the “Executive”) and
is effective on the date signed by both the Executive and on behalf of the Company below (the “Effective Date”).
WHEREAS, the Company and the Executive are parties
to an employment agreement signed on September 15, 2021 (“Prior Agreement”) and have mutually agreed to modify the terms of
the Executive’s employment relationship with the Company.
NOW, THEREFORE, in consideration of the mutual
covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,
the parties agree as follows:
1.
Employment.
(a)
Term. The Company shall employ the Executive and the Executive shall be employed by the Company pursuant to this Agreement
commencing as of the Effective Date, and continuing until such employment is terminated in accordance with the provisions hereof (the
“Term”).
(b)
Position and Duties. During the Term, from the Effective Date until the Board of Directors (the “Board”) of
Inspirato Incorporated, a Delaware corporation (the “Parent”) has appointed a different chief financial officer for Parent,
the Executive shall serve as the Chief Financial Officer of Parent and Chief Financial Officer of the Company, and shall have such powers
and duties as may from time to time be prescribed by the Board or Parent’s Chief Executive Officer (the “CEO”). Beginning
on the date of the Board’s appointment of a new chief financial officer for Parent (the “New CFO Appointment Date”),
the Executive will serve as Chief Strategy Officer reporting directly to the CEO with responsibility for such projects as the CEO assigns,
including activities related to corporate strategy, debt and equity capital markets, investor relations, real estate capital formation
and investment, as the CEO from time to time may direct. The Executive shall be based at the Company’s Colorado headquarters and
shall devote the Executive’s full working time and efforts to the business and affairs of the Company. Notwithstanding the foregoing,
the Executive may serve on other boards of directors or engage in religious, charitable, teaching, or other community activities, as long
as such work, services, and activities do not conflict with or interfere with the Executive’s performance of the Executive’s
duties to the Company.
2.
Compensation and Related Matters.
(a)
Base Salary. The Executive’s initial base salary shall continue to be paid at the rate of $450,000 per year. The Executive’s
base salary shall be subject to review and may be increased (but not decreased) from time to time by the Board or the Compensation Committee
of the Board (the “Compensation Committee”). The base salary in effect at any given time is referred to herein as “Base
Salary.” The Base Salary shall be payable in a manner that is consistent with the Company’s usual payroll practices for executive
officers.
(b)
Incentive Compensation. The Executive’s target annual target cash incentive compensation shall be 50% of the Executive’s
Base Salary. The target annual incentive compensation in effect at any given time is referred to herein as “Target Bonus.”
The Target Bonus and the earning of any actual bonus is subject to the terms of any applicable incentive compensation plan that may be
in effect from time to time with the earned amount, which could be $0 if the metrics in the incentive compensation plan are not met, to
be approved by the Compensation Committee. Any bonus earned will be paid no later than March 15 of the year following the year to which
it relates and to earn incentive compensation, the Executive must be employed by the Company on the day such incentive compensation is
paid
(c)
Expenses. The Executive shall be entitled to receive prompt reimbursement for all reasonable expenses incurred by the Executive
during the Term in performing services hereunder, in accordance with the policies and procedures then in effect and established by the
Company for similar executives.
(d)
Other Benefits. The Executive shall be eligible to participate in or receive benefits under the Company’s employee
benefit plans in effect from time to time, subject to the terms of such plans. Additionally, the Executive shall have benefits under the
Company’s vacation property benefits with benefit levels no less favorable than those provided to similarly situated executives.
(e)
Paid Time Off. The Executive shall be entitled to take paid time off in accordance with the Company’s applicable paid
time off policy for similar executives, as may be in effect from time to time.
(f)
Annual Equity Grants. Any equity compensation awards held by the Executive as of the Effective Date will continue on their
present terms after the Effective Date, except as modified by this Agreement. Executive may be granted
future equity compensation awards in the discretion of the Board or Compensation Committee. Executive will be recommended for awards similar
to those for similarly situated executives.
3.
Termination. The Executive’s employment hereunder may be terminated without any breach of this Agreement under the
following circumstances:
(a)
Death. The Executive’s employment hereunder shall terminate upon death.
(b)
Disability. The Company may terminate the Executive’s employment if the Executive is disabled and unable to perform
or expected to be unable to perform the essential functions of the Executive’s then existing position or positions under this Agreement
with or without reasonable accommodation for a period of 180 consecutive days in any 12-month period. If any question shall arise as to
whether during any period the Executive is disabled so as to be unable to perform the essential functions of the Executive’s then
existing position or positions with or without reasonable accommodation, the Executive may, and at the request of the Company shall, submit
to the Company a certification in reasonable detail by a physician selected by the Executive to whom the Company has no reasonable objection
as to whether the Executive is so disabled or how long such disability is expected to continue, and such certification shall for the purposes
of this Agreement be conclusive of the issue. The Executive shall cooperate with any reasonable request of the physician in connection
with such certification. Nothing in this Section 3(b) shall be construed to waive the Executive’s rights, if any, under existing
law including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. §2601 et seq. and the Americans with
Disabilities Act, 42 U.S.C. §12101 et seq.
(c)
Termination by Company for Cause. The Company may terminate the Executive’s employment hereunder for Cause, as reasonably
determined in good faith by the Company Chief Executive Officer. For purposes of this Agreement, “Cause” shall mean
any of the following:
(i)
misappropriation of funds or property of the Company or any of its subsidiaries or affiliates other than the occasional,
customary and de minimis use of Company property for personal purposes;
(ii)
the Executive’s conviction for, or the Executive’s plea of guilty or no contest to (A) any felony or (B) a
misdemeanor involving moral turpitude;
(iii)
any willful misconduct by the Executive that results in material economic injury to the Company or any of its subsidiaries
or affiliates and that is not cured by the Executive in good faith within a reasonable period of time (not less than 30 days) after the
Executive’s receipt of written notice from the Company specifying the breach;
(iv)
the Executive’s material breach of any written agreement or covenant with the Company that results in material economic
injury to the Company or any of its subsidiaries or affiliates and that is not cured by the Executive in good faith within a reasonable
period of time (not less than 30 days) after the Executive’s receipt of written notice from the Company specifying the breach;
(v)
the Executive’s material violation of any written Company policy that results in material economic injury to the Company
or any of its subsidiaries or affiliates and that is not cured by the Executive in good faith within a reasonable period of time (not
less than 30 days) after the Executive’s receipt of written notice from the Company specifying the violation; or
(vi)
the Executive’s willful failure to cooperate with a bona fide internal investigation or an investigation by regulatory
or law enforcement authorities, after being instructed by the Company to cooperate, or the willful destruction or failure to preserve
documents or other materials known to be relevant to such investigation or the inducement of others to fail to cooperate or to produce
documents or other materials in connection with such investigation, and that is not cured by the Executive in good faith within a reasonable
period of time (not less than 30 days) after the Executive’s receipt of written notice from the Company specifying the violation
If the Executive cures the Cause condition during the applicable cure
period, Cause shall be deemed not to have occurred.
(d)
Termination by the Company without Cause. The Company may terminate the Executive’s employment hereunder at any time
without Cause. Any termination by the Company of the Executive’s employment under this Agreement which does not constitute a termination
for Cause under Section 3(c) and does not result from the death or disability of the Executive under Section 3(a) or (b) shall be deemed
a termination without Cause.
(e)
Termination by the Executive. The Executive may terminate employment hereunder at any time for any reason, including but
not limited to, Good Reason. “Good Reason” shall mean that the Executive has completed all steps of the Good Reason
Process (hereinafter defined) following the occurrence of any of the following events without the Executive’s consent (each, a “Good
Reason Condition”):
(i)
a material diminution in reporting relationship such that the Executive does not report directly to the CEO;
(ii)
a material diminution in the Executive’s Base Salary except for across-the-board salary reductions based on the Company’s
financial performance similarly affecting all or substantially all senior management employees of the Company;
(iii)
a material change in the geographic location at which the Executive provides services to the Company, such that there is
an increase of at least thirty (30) miles of driving distance to such location from the Executive’s principal residence as of such
change; or
(iv)
a material breach by the Company of any agreement between the Executive and the Company.
The “Good Reason Process” consists of the following
steps:
(i)
the Executive reasonably determines in good faith that a Good Reason Condition has occurred;
(ii)
the Executive notifies the Company in writing of the first occurrence of the Good Reason Condition within 60 days of the
first occurrence of such condition;
(iii)
the Executive cooperates in good faith with the Company’s efforts, for a period of not less than 30 days following
such notice (the “Cure Period”), to remedy the Good Reason Condition;
(iv)
notwithstanding such efforts, the Good Reason Condition continues to exist; and
(v)
the Executive terminates employment within 60 days after the end of the Cure Period.
If the Company cures the Good Reason Condition during the Cure Period,
Good Reason shall be deemed not to have occurred.
For this Agreement, “Change in Control” shall mean the
occurrence of any of the following events:
(i)
A change in the ownership of the Company which occurs on the date that any one person, or more than one person acting as
a group (“Person”), acquires ownership of the stock of the Company that, with the stock held by such Person, constitutes more
than 50% of the total voting power of the stock of the Company; provided, that for this subsection, the acquisition of additional stock
by any one Person, who prior to such acquisition is considered to own more than 50% of the total voting power of the stock of the Company
will not be considered a Change in Control. Further, if the stockholders of the Company immediately before such change in ownership continue
to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the Company’s
voting stock immediately prior to the change in ownership, direct or indirect beneficial ownership of 50% or more of the total voting
power of the stock of the Company or of the ultimate parent entity of the Company, such event shall not be considered a Change in Control
under this Section 2(f)(i). For this purpose, indirect beneficial ownership shall include, without limitation, an interest resulting from
ownership of the voting securities of one or more corporations or other business entities which own the Company, as the case may be, either
directly or through one or more subsidiary corporations or other business entities; or
(ii)
A change in the effective control of the Company which occurs on the date a majority of members of the Board is replaced
during any 12-month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior
to the appointment or election. For purposes of this subsection (ii), if any Person is considered to be in effective control of the Company,
the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or
(iii)
A change in the ownership of a substantial portion of the Company’s assets which occurs on the date that any Person
acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such Person or Persons) assets
from the Company that have a total gross fair market value equal to or more than 50% of the total gross fair market value of all of the
assets of the Company immediately prior to such acquisition or acquisitions; provided, that for this subsection (iii), the following will
not constitute a change in the ownership of a substantial portion of the Company’s assets:
(A)
a transfer to an entity controlled by the Company’s stockholders immediately after the transfer, or
(B)
a transfer of assets by the Company to:
(1)
a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company’s stock,
(2)
an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly, by the Company,
(3)
a Person, that owns, directly or indirectly, 50% or more of the total value or voting power of all the outstanding stock of the
Company, or
(4)
an entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by a Person described in
subsection (iii)(B)(1) to subsection (iii)(B)(3).
For this definition, gross fair market value means
the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated
with such assets. For this definition, persons will be acting as a group if they are owners of a corporation that enters into a merger,
consolidation, purchase or acquisition of stock, or similar business transaction with the Company. For the avoidance of doubt, wholly-owned
subsidiaries of the Company shall not be considered “Persons” for purposes of this definition of Change in Control.
(iv)
A transaction will not be a Change in Control:
(A)
unless the transaction qualifies as a change in control event within the meaning of Section 409A of the Internal Revenue
Code (the “Code”); or
(B)
if its primary purpose is to (1) change the jurisdiction of the Company’s incorporation, or (2) create a holding company
owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.
(f)
Payment of Accrued Obligations. If the Executive’s employment with the Company is terminated for any reason, the Company
shall pay or provide to the Executive (or to the Executive’s authorized representative or estate) (i) any Base Salary earned through
the Date of Termination; (ii) unpaid expense reimbursements (subject to, and in accordance with, Section 2(c) of this Agreement); and
(iii) any vested benefits the Executive may have under any employee benefit plan of the Company through the Date of Termination, which
vested benefits shall be paid and/or provided in accordance with the terms of such employee benefit plans (collectively, the “Accrued
Obligations”).
4.
Notice and Date of Termination.
(a)
Notice of Termination. Except for termination as specified in Section 3(a), any termination of the Executive’s employment
by the Company or any such termination by the Executive shall be communicated by written Notice of Termination to the other party hereto.
For purposes of this Agreement, a “Notice of Termination” shall mean a notice which shall indicate the specific termination
provision in this Agreement relied upon.
(b)
Date of Termination. “Date of Termination” shall mean: (i) if the Executive’s employment is terminated
by death, the date of death; (ii) if the Executive’s employment is terminated on account of disability under Section 3(b) or by
the Company for Cause under Section 3(c), the date on which Notice of Termination is given; (iii) if the Executive’s employment
is terminated by the Company without Cause under Section 3(d), the date on which a Notice of Termination is given or the date otherwise
specified by the Company in the Notice of Termination; (iv) if the Executive’s employment is terminated by the Executive under Section
3(e) other than for Good Reason, 14 days after the date on which a Notice of Termination is given, and (v) if the Executive’s employment
is terminated by the Executive under Section 3(e) for Good Reason, the date on which a Notice of Termination is given after the end of
the Cure Period. Notwithstanding the foregoing, in the event that the Executive gives a Notice of Termination to the Company, the Company
may unilaterally accelerate the Date of Termination and such acceleration shall not result in a termination by the Company for purposes
of this Agreement.
5.
Severance Pay and Benefits Upon Termination. If the Executive’s employment is terminated for any reason other than
as provided in Section 3(a) or 3(c), then, in addition to the Accrued Obligations, and subject to (i) the Executive signing a separation
and release agreement in substantially the form attached hereto as Exhibit A, with such changes as necessary to address changes in the
law (the “Separation and Release Agreement”), (ii) the Separation and Release Agreement becoming irrevocable, and (iii) the
Executive truthfully signing any subcertification reasonably requested by Parent that the CEO and chief financial officer of Parent can
rely upon when making the certifications required by Exchange Act Rules 13a-14(A) and 15d-15(A), as adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002, all within 60 days after the Date of Termination (or such shorter period as set forth in the Separation
and Release Agreement), which shall include a seven (7) business day revocation period, the Company shall:
(a)
pay the Executive an amount equal to twenty-four (24) months of the Executive’s Base Salary (the “Severance Amount”);
(b)
pay the Executive (i) any incentive compensation pursuant to Section 2(b) of this Agreement determined to have been earned in respect
of the year preceding the year of termination but not yet paid and (ii) 200% of the Executive’s Target Bonus for the then-current
year;
(c)
notwithstanding anything to the contrary in any applicable option agreement or other stock-based award agreement, take action to
ensure that (i) in the event a Change in Control has occurred prior to, occurs concurrent with, or occurs within three months following
the Date of Termination, all time-based stock options and other stock-based awards subject to only time-based vesting held by the Executive
(the “Time-Based Equity Awards”) shall immediately accelerate and become fully exercisable or nonforfeitable, and (ii) in
the event a Change of Control has not occurred prior to, does not occur concurrent with, and does not occur within three months following
the Date of Termination, 50% of the total amount of all outstanding and unvested equity-securities subject to Time-Based Equity Awards
(as measured by the number of shares of the Parent’s Class A Common Stock or equivalent equity securities covered by such Time-Based
Equity Awards on a fully diluted basis), calculated ratably across all future scheduled vesting events as of the Date of Termination,
shall immediately accelerate and become fully exercisable or nonforfeitable and, provided that either (a) the Date of Termination is after
six (6) month anniversary of the Effective Date or (b) the termination is before the six (6) month anniversary of the Effective Date and
is by the Company under Section 3(d) or by the Executive under Section 3(e), then a number of the then-unvested and outstanding equity
securities subject to the remaining Time-Based Equity Awards shall immediately become fully exercisable and nonforfeitable equal to the
number of unvested equity securities that would have vested with continued service through the next twelve (12) months following the Date
of Termination; provided that Time-Based Equity Awards that accelerate pursuant to this sentence shall accelerate in the following order:
first ratably with respect to all Time-Based Equity Awards other than restricted stock unit awards, and second, ratably with respect to
all restricted stock unit awards (by way of example, if a termination occurs pursuant to which 50,000 equity securities accelerate pursuant
to this sentence, and on the Date of Termination the Executive holds 100,000 equity securities subject to profits interests and 50,000
subject to restricted stock unit awards, then 50,000 equity securities subject to profits interests will accelerate (with such acceleration
applied ratably with respect to each such profits interest), and no equity securities subject to restricted stock units will accelerate).
In all such cases, the applicable Time-Based Equity Awards will accelerate and/or become fully exercisable and non-forfeitable as of the
later of (x) the Date of Termination or (y) the effective date of the Separation Agreement and Release (the “Accelerated Vesting
Date”) and the post-termination exercise period for any stock options will be extended for one year after termination of employment
(unless the stock option terminates earlier because it has reached its maximum term or in connection with a change in control). For avoidance
of doubt, any severance protections applicable to performance-based equity awards will be set out in the agreements governing such awards;
and
(d)
subject to the Executive’s copayment of premium amounts at the applicable active employees’ rate and the Executive’s
proper election to receive benefits under COBRA, pay to the group health plan provider, the COBRA provider or the Executive a monthly
payment equal to the monthly employer contribution that the Company would have made to provide health insurance to the Executive if the
Executive had remained employed by the Company until the earliest of (A) the twenty-four (24) month anniversary of the Date of Termination;
(B) the Executive’s eligibility for group medical plan benefits under any other employer’s group medical plan; or (C) the
cessation of the Executive’s continuation rights under COBRA; provided, however, if the Company determines that it cannot pay such
amounts to the group health plan provider or the COBRA provider (if applicable) without potentially violating applicable law (including,
without limitation, Section 2716 of the Public Health Service Act), then the Company shall convert such payments to payroll payments directly
to the Executive for the time period specified above. Such payments shall be subject to tax-related deductions and withholdings and paid
on the Company’s regular payroll dates.
The amounts payable under Section 5(a) and Section 5(b) shall be paid
out in substantially equal bi-monthly installments with the number of installments equal to two (2) multiplied by the number of months
based on which the Severance Amount is determined in accordance with the Company’s payroll practice commencing within 60 days after
the Date of Termination; provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year,
the Severance Amount, to the extent it qualifies as “non-qualified deferred compensation” within the meaning of Section 409A
of the Code, shall begin to be paid in the second calendar year by the last day of such 60-day period; provided, further, that the initial
payment shall include a catch-up payment to cover amounts retroactive to the day immediately following the Date of Termination. Notwithstanding
the prior sentence, any earned but unpaid bonus for a prior year will be paid on the date that the first of the equal installments is
paid. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section
1.409A-2(b)(2).
6.
Limitation.
(a)
Anything in this Agreement to the contrary notwithstanding, in the event that the amount of any compensation, payment or distribution
by the Company to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of
this Agreement or otherwise, calculated in a manner consistent with Section 280G of the Code, and the applicable regulations thereunder
(the “Aggregate Payments”), would be subject to the excise tax imposed by Section 4999 of the Code, then the Aggregate Payments
shall be reduced (but not below zero) so that the sum of all of the Aggregate Payments shall be $1.00 less than the amount at which the
Executive becomes subject to the excise tax imposed by Section 4999 of the Code; provided that such reduction shall only occur if it would
result in the Executive receiving a higher After Tax Amount (as defined below) than the Executive would receive if the Aggregate Payments
were not subject to such reduction. In such event, the Aggregate Payments shall be reduced in the following order, in each case, in reverse
chronological order beginning with the Aggregate Payments that are to be paid the furthest in time from consummation of the transaction
that is subject to Section 280G of the Code: (1) cash payments not subject to Section 409A of the Code; (2) cash payments subject to Section
409A of the Code; (3) equity-based payments and acceleration; and (4) non-cash forms of benefits; provided that in the case of all the
foregoing Aggregate Payments all amounts or payments that are not subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b)
or (c) shall be reduced before any amounts that are subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b) or (c).
(b)
For purposes of this Section 6(b), the “After Tax Amount” means the amount of the Aggregate Payments less all federal,
state, and local income, excise and employment taxes imposed on the Executive as a result of the Executive’s receipt of the Aggregate
Payments. For purposes of determining the After Tax Amount, the Executive shall be deemed to pay federal income taxes at the highest marginal
rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and
local income taxes at the highest marginal rates of individual taxation in each applicable state and locality, net of the maximum reduction
in federal income taxes which could be obtained from deduction of such state and local taxes.
(c)
The determination as to whether a reduction in the Aggregate Payments shall be made pursuant to Section 6(b) shall be made by a
nationally recognized accounting or valuation firm selected by the Company (the “Accounting Firm”), which shall provide detailed
supporting calculations both to the Company and the Executive within 15 business days of the Date of Termination, if applicable, or at
such earlier time as is reasonably requested by the Company or the Executive. Any determination by the Accounting Firm shall be binding
upon the Company and the Executive.
7.
Section 409A.
(a)
Anything in this Agreement to the contrary notwithstanding, if at the time of the Executive’s separation from service within
the meaning of Section 409A of the Code, the Company determines that the Executive is a “specified employee” within the meaning
of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that the Executive becomes entitled to under this Agreement
or otherwise on account of the Executive’s separation from service would be considered deferred compensation otherwise subject to
the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i)
of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (A) six months
and one day after the Executive’s separation from service, or (B) the Executive’s death. If any such delayed cash payment
is otherwise payable on an installment basis, the first payment shall include a catch-up payment covering amounts that would otherwise
have been paid during the six-month period but for the application of this provision, and the balance of the installments shall be payable
in accordance with their original schedule.
(b)
All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company or
incurred by the Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively
practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which
the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect
the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other
aggregate limitation applicable to medical expenses). Such right to reimbursement or in-kind benefits is not subject to liquidation or
exchange for another benefit.
(c)
To the extent that any payment or benefit described in this Agreement constitutes “non-qualified deferred compensation”
under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Executive’s termination of employment,
then such payments or benefits shall be payable only upon the Executive’s “separation from service.” The determination
of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation
Section 1.409A-1(h).
(d)
The parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any
provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in such a manner
so that all payments hereunder comply with Section 409A of the Code. Each payment pursuant to this Agreement or the Restrictive Covenants
Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2). The parties agree that
this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section 409A of the
Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to
either party.
(e)
The Company makes no representation or warranty and shall have no liability to the Executive or any other person if any provisions
of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption
from, or the conditions of, such Section.
8.
Continuing Obligations.
(a)
Proprietary Rights and Inventions Assignment Agreement. The Executive is party to the Proprietary Rights and Inventions
Assignment Agreement, attached hereto as Exhibit B (the “PRIA”). The Executive acknowledges that during the term of
his employment, he has had and will continue to have access to trade secrets of the Company and/or be part of the Company’s management
team. Therefore, for the period of his employment by the Company and continuing until one year after his Date of Termination, regardless
of the reason for the termination of his employment, the Executive agrees that he shall not, without the prior written consent of the
Company, directly or indirectly, own, invest in, manage, operate, control or advise or join in or participate in the ownership, management,
operation or control of or be employed by or connected in any manner with any businesses that sell, market, operate or have investment
in; villa rental, fractional ownership, cooperative vacation club, home exchange and/or luxury destination club or any entity in the United
States which is in direct competition with the Company’s Business and acknowledges that the agreement not to compete set forth in
this provision is both reasonable and necessary for the protection of the Company’s trade secrets, as contemplated by CO Rev. Stat.
§ 8-2-113(2)(b). For purposes of this Agreement, the Company’s Business shall mean the Company’s business on the Executive’s
Date of Termination, including all prior products, services or diversified lines of business. For purposes of this Agreement, the obligations
in this Section 8 and those that arise in the PRIA and any other agreement relating to confidentiality, assignment of inventions, or other
restrictive covenants shall collectively be referred to as the “Continuing Obligations.” The parties agree that the value
of the Continuing Obligations to the Company is no less than the value of any severance amounts paid to the Executive.
(b)
Non-Solicitation. For the period of my employment by the Company and continuing until two years after my last day of employment
with the Company, regardless of the reason for the termination of my employment, I will not directly or indirectly induce any employee
of the Company to terminate or negatively alter his or her relationship with the Company.
(c)
Third-Party Agreements and Rights. The Executive hereby confirms that the Executive is not bound by the terms of any agreement
with any previous employer or other party which restricts in any way the Executive’s use or disclosure of information, other than
confidentiality restrictions (if any), or the Executive’s engagement in any business. The Executive represents to the Company that
the Executive’s execution of this Agreement, the Executive’s employment with the Company and the performance of the Executive’s
proposed duties for the Company will not violate any obligations the Executive may have to any such previous employer or other party.
In the Executive’s work for the Company, the Executive will not disclose or make use of any information in violation of any agreements
with or rights of any such previous employer or other party, and the Executive will not bring to the premises of the Company any copies
or other tangible embodiments of non-public information belonging to or obtained from any such previous employment or other party.
(d)
Litigation and Regulatory Cooperation. During and after the Executive’s employment, the Executive shall cooperate
fully with the Company in (i) the defense or prosecution of any claims or actions now in existence or which may be brought in the future
against or on behalf of the Company which relate to events or occurrences that transpired while the Executive was employed by the Company,
and (ii) the investigation, whether internal or external, of any matters about which the Company believes the Executive may have knowledge
or information. The Executive’s full cooperation in connection with such claims, actions or investigations shall include, but not
be limited to, being available to meet with counsel to answer questions or to prepare for discovery or trial and to act as a witness on
behalf of the Company at mutually convenient times. During and after the Executive’s employment, the Executive also shall cooperate
fully with the Company in connection with any investigation or review of any federal, state or local regulatory authority as any such
investigation or review relates to events or occurrences that transpired while the Executive was employed by the Company. The Company
shall reimburse the Executive for any reasonable out-of-pocket expenses.
(e)
Relief. The Executive agrees that it would be difficult to measure any damages caused to the Company which might result
from any breach by the Executive of the Continuing Obligations, and that in any event money damages would be an inadequate remedy for
any such breach. Accordingly, the Executive agrees that if the Executive breaches, or proposes to breach, any portion of the Continuing
Obligations, the Company shall be entitled, in addition to all other remedies that it may have, to an injunction or other appropriate
equitable relief to restrain any such breach without showing or proving any actual damage to the Company.
9.
Arbitration of Disputes.
(a)
Arbitration Generally. Any controversy or claim arising out of or relating to this Agreement or the breach thereof or otherwise
arising out of the Executive’s employment or the termination of that employment shall, to the fullest extent permitted by law, be
settled by arbitration in any forum and form agreed upon by the parties or, in the absence of such an agreement, under the auspices of
JAMS in Denver, Colorado in accordance with the JAMS Employment Arbitration Rules, including, but not limited to, the rules and procedures
applicable to the selection of arbitrators. The Executive understands that the Executive may only bring such claims in the Executive’s
individual capacity, and not as a plaintiff or class member in any purported class proceeding or any purported representative proceeding.
The Executive further understands that, by signing this Agreement, the Company and the Executive are giving up any right they may have
to a jury trial on all claims they may have against each other. Judgment upon the award rendered by the arbitrator may be entered in any
court having jurisdiction thereof. This Section 9 shall be specifically enforceable. Notwithstanding the foregoing, this Section 9 shall
not preclude either party from pursuing a court action for the sole purpose of obtaining a temporary restraining order or a preliminary
injunction in circumstances in which such relief is appropriate, including without limitation relief sought under the Restrictive Covenants
Agreement; provided that any other relief shall be pursued through an arbitration proceeding pursuant to this Section 9.
(b)
Arbitration Fees and Costs. The Executive shall be required to pay an arbitration fee to initiate any arbitration equal
to what the Executive would be charged as a first appearance fee in court. The Company shall advance the remaining fees and costs of the
arbitrator. However, to the extent permissible under the law, and following the arbitrator’s ruling on the matter, the arbitrator
may rule that the arbitrator’s fees and costs be distributed in an alternative manner. Each party shall pay its own costs and attorneys’
fees, if any. If, however, any party prevails on a statutory or contractual claim that affords the prevailing party attorneys’ fees
(including pursuant to this Agreement), the arbitrator may award attorneys’ fees to the prevailing party to the extent permitted
by law.
10.
Consent to Jurisdiction. To the extent that any court action is permitted consistent with or to enforce Section 9 of this
Agreement, the parties hereby consent to the jurisdiction of the state and federal courts of the State of Colorado. Accordingly, with
respect to any such court action, the Executive (a) submits to the exclusive personal jurisdiction of such courts; (b) consents to service
of process; and (c) waives any other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction
or service of process.
11.
Waiver of Jury Trial. Each of the Executive and the Company irrevocably and unconditionally waives
all right to trial by jury in any Proceeding (whether based on contract, tort or otherwise) arising out of or relating to this Agreement
or THE EXECUTIVE’s employment by the Company or any affiliate of the Company, INCLUDING WITHOUT LIMITATION THE EXECUTIVE’S
or the Company’s performance under, or the enforcement of, this Agreement.
12.
Integration. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof
and supersedes all prior agreements between the parties concerning such subject matter, provided that the Restrictive Covenants Agreement
and the Equity Documents remain in full force and effect.
13.
Withholding; Tax Effect. All payments made by the Company to the Executive under this Agreement shall be net of any tax
or other amounts required to be withheld by the Company under applicable law. Nothing in this Agreement shall be construed to require
the Company to make any payments to compensate the Executive for any adverse tax effect associated with any payments or benefits or for
any deduction or withholding from any payment or benefit.
14.
Assignment. Neither the Executive nor the Company may make any assignment of this Agreement or any interest in it, by operation
of law or otherwise, without the prior written consent of the other; provided, however, that the Company may assign its rights and obligations
under this Agreement (including the Restrictive Covenants Agreement) without the Executive’s consent to any affiliate or to any
person or entity with whom the Company shall hereafter effect a reorganization, consolidate with, or merge into or to whom it transfers
all or substantially all of its properties or assets; provided further that if the Executive remains employed or becomes employed by the
Company, the purchaser or any of their affiliates in connection with any such transaction, then the Executive shall not be entitled to
any payments, benefits or vesting pursuant to Section 5 of this Agreement solely as a result of such transaction but the transaction may
result in a change in the Executive’s position that would entitle him to resign for Good Reason and receive benefits under Section
5. This Agreement shall inure to the benefit of and be binding upon the Executive and the Company, and each of the Executive’s and
the Company’s respective successors, executors, administrators, heirs and permitted assigns.
15.
Enforceability. If any portion or provision of this Agreement (including, without limitation, any portion or provision of
any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the
remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared
illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable
to the fullest extent permitted by law.
16.
Survival. The provisions of this Agreement shall survive the termination of this Agreement and/or the termination of the
Executive’s employment to the extent necessary to effectuate the terms contained herein.
17.
Waiver. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The
failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach
of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.
18.
Notices. Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if in
writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage
prepaid, return receipt requested, to the Executive at the last address the Executive has filed in writing with the Company or, in the
case of the Company, at its main offices, attention of the Board.
19.
Amendment. This Agreement may be amended or modified only by a written instrument signed by the Executive and by a duly
authorized representative of the Company and no subsequent writing will abrogate the Executive’s rights under this Agreement without
specifically mentioning and waiving this Section 19.
20.
Effect on Other Plans and Agreements. An election by the Executive to resign for Good Reason under the provisions of this
Agreement shall not be deemed a voluntary termination of employment by the Executive for the purpose of interpreting the provisions of
any of the Company's benefit plans, programs or policies. Nothing in this Agreement shall be construed to limit the rights of the Executive
under the Company’s benefit plans, programs or policies except as otherwise provided in Section 8 hereof, and except that the Executive
shall have no rights to any severance benefits under any Company severance pay plan, offer letter or otherwise. In the event that the
Executive is party to an agreement with the Company providing for payments or benefits under such plan or agreement and under this Agreement,
the terms of this Agreement shall govern and the Executive may receive payment under this Agreement only and not both. The provisions
of the prior sentence will not apply to any performance-based equity grants and any severance protections set forth in the award agreements
for such performance-based equity grants will govern.
21.
Governing Law. This is a Colorado contract and shall be construed under and be governed in all respects by the laws of the
State of Colorado, without giving effect to the conflict of laws principles thereof. With respect to any disputes concerning federal law,
such disputes shall be determined in accordance with the law as it would be interpreted and applied by the United States Court of Appeals
for the Tenth Circuit.
22.
Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered
shall be taken to be an original; but such counterparts shall together constitute one and the same document.
IN WITNESS WHEREOF, the parties have executed this
Agreement effective on the Effective Date.
|
INSPIRATO LLC |
|
|
|
|
By: |
/s/ Brent Handler |
|
|
Brent Handler |
|
|
|
|
Its: |
Chief Executive Officer |
|
|
|
|
Date: |
March 15, 2023 |
|
|
|
EXECUTIVE |
|
|
|
|
By: |
/s/ Web Neighbor |
|
|
Web Neighbor |
|
|
|
|
Date: |
March 15, 2023 |
Exhibit A
Separation and Release Agreement
This Separation and Release Agreement (“Agreement”)
is made between Inspirato LLC, a Delaware limited liability company (the “Company”) and [•] (“Executive”)
(each a “party” and together the “parties”):
WHEREAS, the Executive was employed by the Company;
WHEREAS, the Executive has separated from employment
with the Company effective [insert date] (“Separation Date”);
WHEREAS, the parties wish to ensure an amicable
separation and to provide for the release in full of all claims by the Executive;
NOW, THEREFORE, the parties agree as follows:
1.
Separation Benefits. Provided that the Executive complies with all conditions described in Section 3 of this Agreement (the
“Conditions”), the Company shall provide the following separation benefits to the Executive: [TO INSERT PER EMPLOYMENT
AGREEMENT]
2.
Release in Full of All Claims. In exchange for the promises described in Section 1 of this Agreement, the Executive, for
himself/herself and his/her heirs, assigns and personal representatives, fully and completely releases the Company and its parents, subsidiaries
and affiliated entities and all predecessors and successors thereto, and all benefit plans thereof, and all of their respective shareholders,
members, partners, directors, officers, managers, employees, attorneys, administrators and agents (each a “Releasee”
and collectively the “Releasees”) from any and all claims or causes of action that the Executive may have against the
Releasees, known or unknown, including claims or causes of action that relate in any way to the Executive’s employment with any
Releasee or the termination thereof, from the beginning of time through the date the Executive signs this Agreement (each a “Released
Claim” and together the “Released Claims”), including but not limited to the following:
(a) federal,
state or local laws prohibiting discrimination (including harassment and retaliation) in employment, such as: (i) the Age Discrimination
in Employment Act (“ADEA”), the Older Workers Benefit Protection Act, and the Executive Order 11141, which prohibit
discrimination based on age; (ii) Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1866 (42 U.S.C. § 1981),
the Equal Pay Act, and the Executive Order 11246, which prohibit discrimination based on race, color, national origin, religion, or sex;
(iii) the Genetic Information Nondiscrimination Act, which prohibits discrimination on the basis of genetic information; (iv) the Americans
With Disabilities Act and Sections 503 and 504 of the Rehabilitation Act of 1973, which prohibit discrimination based on disability; (v)
the National Labor Relations Act, which prohibits discrimination for engaging in certain concerted protected activity; (vi) the Occupational
Safety and Health Act and the Mine Safety and Health Act, which prohibit discrimination for engaging in certain safety-related activity;
(vii) the Sarbanes Oxley Act, which prohibits discrimination for engaging in certain whistleblowing activity; and (viii) the Colorado
Anti-Discrimination Act (C.R.S. 24-34-301 et seq. and 24-34-401 et seq.), which prohibits discrimination on many of the bases described
above;
(b) federal,
state or local laws regarding wages and hours, including laws regarding minimum wage, overtime compensation, wage payment, vacation pay,
sick pay, compensatory time, commissions, bonuses, and meal and break periods wages, such as the Fair Labor Standards Act and the Colorado
Wage Claim Act (C.R.S. 8-4-101 et seq.);
(c) other
employment laws, including but not limited to: (i) the Family and Medical Leave Act, which requires employers to provide leaves of absence
under certain circumstances; (ii) the Worker Adjustment and Retraining Notification Act (WARN), which requires advance notice of certain
workforce reductions; (iii) the Employee Retirement Income Security Act, which protects employee benefits (among other things); and (iv)
the Uniformed Services Employment and Reemployment Rights Act, which requires employers to provide military leave under certain circumstances;
and
(d) any
common law theory, including but not limited to breach of contract (expressed or implied), promissory estoppel, wrongful discharge, outrageous
conduct, defamation, fraud or misrepresentation, tortious interference, invasion of privacy, negligent hiring or supervision, or any other
claims based in contract, tort or equity.
Notwithstanding the foregoing, the Released Claims do not include claims
for breach of this Agreement, claims related to rights to indemnification or insurance the Executive has pursuant to contractual arrangements
with the Company or its parent, corporate documents of the Company or its parent, claims that arise after the Executive signs this Agreement,
claims for vested pension benefits, claims for workers’ compensation benefits or unemployment compensation benefits, and any other
claims that cannot by law be released by private agreement. In addition, this release does not prevent the Executive from filing: (i)
a lawsuit to challenge the effectiveness of a release of claims of age discrimination under the ADEA; or (ii) a charge with a governmental
agency, including but not limited to the U.S. Equal Employment Opportunity Commission (“EEOC”) and the U.S. Securities
and Exchange Commission (“SEC”), but the Executive is waiving his/her right to recover any monetary or injunctive relief pursuant
to any such charge. Notwithstanding the foregoing, this Agreement does not prevent the Executive from recovering an award from or by a
governmental agency for providing information.
Executive acknowledges and agrees that the Executive is releasing both
known and unknown claims and waives the benefit of any statute purporting to prevent the Executive from releasing unknown claims, including
but not limited to the protection of Cal. Civ. Code Section 1542, which states:
A general release does not extend to claims that the creditor
or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him
or her, would have materially affected his or her settlement with the debtor or released party.
3.
Conditions. The Executive shall comply with the following terms, as conditions of payment, and in the event that the Executive
fails to satisfy these conditions, the Company shall have no obligation to provide any separation benefits pursuant to Section 1 and shall
be entitled to a refund of any separation benefits previously paid:
(a) Execution
and Return of Agreement. The Executive shall sign this Agreement and return the signed original of the Agreement to the Company within
twenty-one (21) days after the Separation Date and shall not revoke it, except as otherwise described in Section 6, below.
(b) Property. The Executive shall
return all Company property in the Executive’s possession, custody or control on or before the Separation Date, including but not
limited to all motor vehicles, computer hardware, office equipment, tools, telephones, credit cards, keys, card keys, and the originals
and all copies of all documents, files, computer software and electronic data (including any and all copies of the Company’s proprietary
software, commensurate source code and engineering designs); provided, however, that the Executive may retain copies of documents reflecting
the Executive’s compensation and benefits from the Company. By signing this Agreement, the Executive represents and warrants that
the Executive has fully complied with this Section 3(b).
(c) Non-Disparagement. The Executive
shall not malign or disparage any of the Releasees or the Company’s business, products, services, customers or clients. The Company
shall direct its officers and directors to not malign or disparage the Executive. Nothing in this Agreement shall preclude a party from:
(i) reporting violations of law to law enforcement officials; (ii) giving truthful testimony under oath in a judicial, administrative,
or arbitral proceeding; or (iii) making truthful statements to governmental agencies (including but not limited to the EEOC and SEC).
By signing this Agreement, the Executive represents and warrants that the Executive has fully complied with this Section 3(c).
(d) Confidential Information.
(i) Executive shall not disclose to any
third party, or use for the benefit of the Executive or any third party, any Confidential Information. For purposes of this Agreement,
“Confidential Information” shall mean: (A) all trade secrets of the Releasees, as that term is defined in the Colorado
Uniform Trade Secrets Act, C.R.S. 7-74-101 et seq.; (B) all intellectual property of the Releasees, including but not limited to all inventions,
discoveries, ideas or processes that have been or could be protected by patent, trademark, copyright or similar protections; (C) all communications
or information to or from counsel for any of the Releasees that constitute attorney work product or are protected by attorney-client privilege;
and (D) all other non-public information concerning the business or operations of the Releasees, including but not limited to information
concerning organization, management, finances, business plans and strategies, clients and customers, relationships with contractors and
vendors, proprietary or specialized computer software, employees, products and services, equipment and systems, methods, processes and
techniques, and prospective and executed contracts and other business arrangements.
(ii) In
response to any subpoena, court order or other legal process purporting to require disclosure of Confidential Information, the Executive
shall: (A) immediately notify the Company; (B) take all lawful steps, at the Company’s expense, to resist the subpoena, court order
or other process unless otherwise directed by the Company; and (C) cooperate fully, at the Company’s expense, with all lawful efforts
by the Company to protect the Confidential Information from disclosure.
(iii) Notwithstanding
the foregoing, 18 U.S.C. §1833(b) provides, in part: “(1) An individual shall not be held criminally or civilly liable under
any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or
local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating
a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is
made under seal. (2) An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose
the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A)
files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order.”
Nothing in this Agreement, any other agreement executed by the Executive, or any Company policy is intended to conflict with this statutory
protection.
(e) Other Agreements. The Executive
shall fully comply with all other agreements between the Executive and the Company (or any parent, subsidiary or affiliate of the Company
or predecessor or successor thereto), including but not limited to the attached Proprietary Rights and Inventions Assignment Agreement,
the Continuing Obligations set forth in the Employment Agreement between the Executive and the Company signed on [•], and any other
agreements regarding confidentiality, protection of intellectual property, noncompetition, or nonsolicitation (each an “Other
Agreement”); provided, however, that in the event of any conflict between any provision of this Agreement and a provision of
an Other Agreement, the provision providing the greater protection to the Company shall control.
(f) Cooperation
and Assistance. For a period of one year from and after the Separation Date, the Executive shall cooperate with and assist the Company,
without out-of-pocket expense to the Executive, by sharing the knowledge the Executive has gained during the course of employment with
the Company as reasonably requested by the Company.
4.
No Other Claims. The Executive represents and warrants that:
(a)
Executive has no Released Claims pending against the Company or any other Releasee and has not assigned or transferred any Released
Claim to anyone;
(b)
Executive has been timely paid all compensation owed for services rendered through the Separation Date, including all salary, wages,
bonuses, commissions, overtime compensation (if applicable) and payment for all accrued but unused vacation, and has timely received all
meal periods and rest breaks to which the Executive may have been entitled;
(c)
Executive has been fully reimbursed for all business expenses incurred by the Executive for which the Executive was entitled to
reimbursement;
(d)
Executive has not suffered any work-related injury or illness as an employee of the Company or any other Releasee and is not aware
of any facts or circumstances that would give rise to a workers’ compensation claim by the Executive against the Company or any
other Releasee; and
(e)
Executive has not suffered any sexual harassment or sexual abuse as an employee of the Company or any other Releasee and is not
aware of any facts or circumstances that would give rise to such a claim by the Executive against the Company or any other Releasee.
5.
Acknowledgements. By signing this Agreement, the Executive acknowledges and agrees that:
(a) the
consideration described in Section 1 of this Agreement is consideration to which the Executive would not otherwise be entitled, but for
the signing of this Agreement;
(b) Executive
has been advised to consult with legal counsel and a tax professional, including with regard to Section 409A, as defined below, about
this Agreement and has been given an opportunity to do so;
(c) Executive
has been given the amount of time specified in Section 3(a) within which to consider this Agreement before signing it, any changes to
this Agreement did not restart the consideration period, and if the Executive has signed this Agreement in less than the specified consideration
period, the Executive has done so voluntarily;
(d) Executive
is not relying on any promises or representations of any kind, except those set forth in this Agreement; and
(e) Executive
has signed this Agreement voluntarily, of the Executive’s own free will, and without any threat, intimidation or coercion.
6.
Revocation. The Executive may revoke this Agreement by delivering written notice of revocation to the Company by email,
delivery or U.S. Mail addressed as follows, which notice must be received not later than the seventh (7th) calendar day following the
Executive’s signing of this Agreement, and this Agreement shall not become effective until the seven-day revocation period has expired
without revocation by the Executive:
Inspirato LLC
1544 Wazee Street
Denver, CO 80202
Email: [•]@inspirato.com
Attn: [•]
7.
Confidentiality. The existence and terms of this Agreement are strictly confidential and shall not be disclosed by the Executive
to anyone except (a) the Executive’s spouse, attorneys and tax advisors, and then only after securing their agreement to be bound
by this provision; or (b) in response to inquiry from a taxing authority or otherwise as required by law.
8.
Invalidity of Release. If any provision of Section 2 of this Agreement is held to be invalid or unenforceable and the Executive
is permitted to and does assert any Released Claim against a Releasee, the Company shall be entitled to an immediate refund of one hundred
percent (100%) of all payments made pursuant to Section 1 of this Agreement, in addition to any other remedy available to the Company
under law or equity; provided, however, that this provision shall not apply to a claim of age discrimination under the ADEA unless ordered
by a court of law.
9.
Severability. If any provision of this Agreement is held to be invalid or unenforceable, the remaining provisions shall
be unaffected and shall continue in full force and effect.
10.
No Admission. The parties agree that this Agreement is not an admission, and shall not be construed as an admission, by
either Party of any violation of law or other wrongdoing of any kind.
11.
Attorney Fees and Costs. In any litigation, arbitration or other proceeding arising out of or relating to this Agreement,
the prevailing party shall be entitled to recover his/her/its reasonable attorney fees and costs; provided, however, that this provision
shall not apply to a claim of age discrimination under the ADEA or a suit challenging the validity of a release of age discrimination
claims under the ADEA.
12.
Controlling Law; Venue. This Agreement shall be governed by the laws of the State of Colorado, without regard to any state’s
principles regarding conflict of laws; provided, however, that this Agreement shall be governed by the laws of the State of California
if the Executive’s principal work location as of the Separation Date was in California. Any action arising out of or relating to
this Agreement shall be brought only in the state or federal courts in or for Denver, Colorado and the Executive and the Company hereby
waive any right that they might have to challenge the selection of those forums, including but not limited to challenges to personal jurisdiction,
venue, or the convenience of the forum.
13.
Code Section 409A. This Agreement is intended to comply with Section 409A of the Internal Revenue Code of 1986, as amended
(“Section 409A”), or an exemption thereto, and payments may only be made under this Agreement upon an event and in
a manner permitted by Section 409A or an exception thereto. Accordingly, this Agreement shall be interpreted in a manner consistent with
the requirements of Section 409A to the extent applicable. Any payments under this Agreement that may be excluded from Section 409A either
as a short-term deferral or as separation pay due to an involuntary separation from service shall be excluded from Section 409A to the
maximum extent possible. All separation payments to be made upon the termination of employment hereunder may only be made upon a “separation
from service” within the meaning of Section 409A. Each amount to be paid or benefit provided under this Agreement shall be construed
as a separate identified payment for purposes of Section 409A. Notwithstanding any other provision in this Agreement or in any other document,
the Company shall not be responsible for the payment of any applicable taxes incurred by the Executive pursuant to this Agreement, under
Section 409A or otherwise. The Company makes no representation that any or all of the payments and benefits described in this Agreement
will be exempt from or comply with Section 409A, and the Executive agrees that the Company is not responsible for any liabilities arising
to the Executive under 409A.
14.
Entire Agreement. This Agreement is the entire agreement between the parties regarding the matters addressed herein, and
it supersedes and replaces all prior agreements, representations, negotiations or discussions between the parties regarding such matters,
whether written or oral. This Agreement may not be modified except in writing signed by both parties. This Agreement may be signed in
counterparts, including fax counterparts, and all counterparts together shall constitute one fully-executed agreement.
IN WITNESS WHEREOF, the parties have executed this
Agreement on the dates stated below.
|
INSPIRATO LLC |
|
|
|
By: |
|
|
|
|
Its: |
|
|
|
|
Date: |
|
|
|
|
EXECUTIVE |
|
|
|
By: |
|
|
|
[•] |
|
|
|
Date: |
|
Exhibit B
Restrictive Covenants Agreement
Exhibit 99.1
Inspirato Announces
2022 Results, CFO Succession Plan and
Provides 2023 Guidance
DENVER,
March 15, 2023 – Inspirato Incorporated (“Inspirato” or the “Company”)
(NASDAQ: ISPO), the innovative luxury travel subscription brand, today announced its 2022 fourth quarter and full-year financial and
operating results and provided updated 2023 guidance.
2022 Fourth Quarter and Full-Year
Highlights:
| ● | Total
Revenue. Total revenue of $87 million for the fourth quarter, representing 27% year-over-year
growth and a 7% sequential decrease compared to the third quarter of 2022. Full-year 2022
revenue was $346 million, 47% year-over-year growth compared to $235 million in 2021. |
| ● | Subscription
Base. Active Subscriptions of 16,100, including 3,600 Inspirato Pass subscriptions at
year-end 2022, representing year-over-year increases of 8% and 19%, respectively, and sequential
quarterly decreases of 1% and 7%, respectively. |
| ● | Strong
Demand. Increased Total Nights Delivered by 31% to 188,000 in 2022 compared to 143,000
in 2021. |
| ● | Portfolio
Optimization. Ended 2022 with 733 Controlled Accommodations, a 36% net increase compared
to 538 Controlled Accommodations at year-end 2021. The Company has moderated its pace of
Controlled Accommodations growth in recent quarters as it focuses on gross margins to drive
future profitability. |
| ● | Expanded
Market with New Offerings. Launched innovative new platforms, Inspirato for Good
(“IFG”) and Inspirato for Business (“IFB”), to expand its Total Addressable
Market and diversify revenue streams. |
2023 Highlights:
| ● | Announced
strategic partnership with Saks, the premier digital platform for luxury fashion. Nearly
3,000 Saks stylists and personal shoppers will be enabled to introduce Inspirato’s
subscription offerings to their luxury customers, both online and in Saks Fifth Avenue stores.
Saks has the opportunity to earn commissions and incentive-based warrants to acquire Inspirato
shares with an exercise price of $2 per share. Based on Saks successfully converting their
digital and in-store customers to paying Inspirato subscribers, Saks may exercise these performance
warrants to acquire up to a cap of approximately 15% of Inspirato’s current total shares
outstanding. |
| ● | The
Company is revising its full-year 2023 revenue guidance downward and now anticipates total
revenue between $350 and $370 million, approximately 4% growth at the mid-point compared
to 2022 as the Company prioritizes accelerating its path to profitability. |
| ● | Anticipated
total operating expense, excluding stock-based compensation, between $135 and $140 million
compared to $153 million in 2022. |
| ● | Anticipated
adjusted EBITDA, a non-U.S. GAAP measure defined below, between a loss of $10 million and
$20 million. |
These statements are forward-looking
and actual results may differ materially. Refer to the Forward-Looking Statements safe harbor below for information on the factors that
could cause our actual results to differ materially from these forward-looking statements.
Forward looking Adjusted EBITDA is a
forward-looking non-GAAP financial measure. The Company is unable to reconcile forward-looking Adjusted EBITDA to net income, its most
directly comparable forward-looking GAAP financial measure, without unreasonable effort, as a result of the uncertainty regarding, and
the potential variability of, reconciling items such as equity-based compensation expense. However, it is important to note that material
changes to reconciling items could have a significant effect on our future GAAP results.